Eli Lilly & Co. (LLY)
Last updated: 2026-11-05 07:24:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,417.84, with a market capitalization of $1.26T and a P/E ratio of 45.52. Over the past 52 weeks, its price has ranged from $850.51 to $1,449.68. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.26T | |
$1,440.00 | |
$1,449.68 | |
$27.21 | |
$1,409.38 | |
2.82M | |
2.49M | |
45.52 | |
$1,449.68 | |
$850.51 | |
0.48% | |
2001-12-30 |
Eli Lilly & Co. (LLY) Latest Closing Stock Price
Eli Lilly & Co. (LLY) last closed at $1,409.38 as of 2026-11-05 00:59:46, unchanged from the previous close of $1,409.38.
During the latest regular trading session, LLY traded between $27.21 and $1,449.68, with a volume of 2.82M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Eli Lilly & Co. (LLY) 7-Day Stock Price Change
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,281.91 to $1,417.84, representing a gain of 10.60% ($135.93).
The stock traded between $1,260.34 and $1,449.68 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3.39 million shares, up versus the previous seven-day period, indicating higher trading activity.
LLY 52-Week Price Position
Position in Range: 94.7%
LLY is currently trading at $1,417.84, placing it 94.7% of the way from its 52-week low of $850.51 to its 52-week high of $1,449.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Eli Lilly & Co. (LLY)?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| CEO | David A. Ricks |
| Founded | 1876 |
| Exchange | NYSE |
| Company Website |
How to Buy Eli Lilly & Co. (LLY) Stock on MEXC
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Eli Lilly & Co. (LLY) stock price today?
2.Is LLY stock going up or down today?
3.What is LLY pre-market price?
4.What is LLY after-hours price?
5.Is LLY stock trading now?
6.Where does LLY sit relative to its 52-week high and low?
7.What sector is Eli Lilly & Co. in?
8.What is Eli Lilly & Co.'s market capitalization and where is it listed?
9.How is LLY valued in terms of P/E ratio and EPS?
10.Does Eli Lilly & Co. pay a dividend?
Explore More US Stocks
Search Stocks
LLY Stock Calculator
Estimate the value between LLY shares and USD.
LLY Shares to USD
1.00 LLY shares = 1,417.843 USD
Calculations are estimates based on the latest available price and are for reference only.



